首页> 外文期刊>Gastrointestinal Endoscopy >The EPISOD study: long-term outcomes
【24h】

The EPISOD study: long-term outcomes

机译:Episod研究:长期成果

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aims The EPISOD (Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction) study randomized patients with post-cholecystectomy pain, and little or no objective evidence for biliary obstruction, to sphincterotomy or sham intervention. Results at 1 year showed no benefit for the active treatment. We now report the outcomes at up to 5 years. Methods One hundred three patients completing 1 year, and still blinded to treatment allocation, were enrolled and followed by phone every 6 months for a median of 58 months (range, 17-71 months). Their success was assessed at the final visit by 2 criteria: (1) a low pain score (Recurrent Abdominal Pain and Disability instrument [RAPID]? Results By the RAPID criteria, success rates for the patients in the sphincterotomy and sham arms were similar: 26/65 (40%) versus 16/38 (42%), respectively. However, by the PGIC criteria, actively treated patients fared worse: 16/43 (37%) versus 16/22 (73%). A total of 75 patients underwent active treatment during the entire study. Their success rate by the RAPID criteria was 31 (41%) compared with 16 (62%) who had no active treatment at any time. Conclusions These data confirm our initial report that endoscopic sphincterotomy is no better than sham intervention in these patients (and, by some criteria, worse), and that ERCP can no longer be recommended. The patients have genuine and often severe symptoms, and further research is needed to establish effective management. (Clinical trial registration number: 00688662 05/3/2008.)
机译:背景并瞄准Episod(评估Oddi功能障碍括约肌中的括约肌中的预测因子和干预)研究随机化胆囊切除术疼痛的患者,并且胆道阻塞的几乎没有客观证据,对括约肌或假干预。结果在1年内显示出于积极治疗没有益处。我们现在报告最多5年的结果。方法三百六个患者完成1年,仍然蒙蔽治疗分配,每6个月入学,然后每6个月内登上手机(范围,17-71个月)。他们的成功在最后一次访问中评估了2个标准:(1)低疼痛评分(复发性腹痛和残疾仪器[Rapid]的效果[Rapid]的结果是相似的患者的成功率相似: 26/65(40%)分别与16/38(42%)(42%)。然而,通过PGIC标准,积极治疗的患者更差:16/43(37%)与16/22(73%)。共75例患者在整个研究期间接受了活跃的治疗。他们的成功率通过快速标准为31(41%),而在任何时候没有活跃治疗的16(62%)。结论这些数据确认了内窥镜括约肌细胞术的初步报告在这些患者中,不得比假干预更好(以及一些标准,更差),并且不再推荐ERCP。患者有真正的,通常是严重的症状,并且需要进一步研究来建立有效的管理。(临床试验登记数字:00688662 05/3/2008。)

著录项

  • 来源
    《Gastrointestinal Endoscopy》 |2018年第1期|共6页
  • 作者单位

    Digestive Disease Center Medical University of South Carolina;

    Department of Public Health Sciences Medical University of South Carolina;

    Division of Gastroenterology and Hepatology Department of Medicine Medical University of South;

    Department of Public Health Sciences Medical University of South Carolina;

    Center for Functional GI and Motility Disorders at University of North Carolina and Drossman;

    Division of Gastroenterology and Hepatology Department of Medicine Medical University of South;

    Department of Public Health Sciences Medical University of South Carolina;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号